Prakadan, Sanjay M.
Alvarez-Breckenridge, Christopher A.
Markson, Samuel C.
Kim, Albert E. http://orcid.org/0000-0003-2359-6209
Klein, Robert H. http://orcid.org/0000-0002-7794-5753
Nayyar, Naema http://orcid.org/0000-0003-3436-8404
Navia, Andrew W.
Kuter, Benjamin M.
Kolb, Kellie E.
Bihun, Ivanna
Mora, Joana L. http://orcid.org/0000-0002-5913-1107
Bertalan, Mia Solana
Shaw, Brian
White, Michael http://orcid.org/0000-0002-3855-9243
Kaplan, Alexander
Stocking, Jackson H. http://orcid.org/0000-0003-2759-2125
Wadsworth, Marc H. II
Lee, Eudocia Q.
Chukwueke, Ugonma
Wang, Nancy
Subramanian, Megha
Rotem, Denisse http://orcid.org/0000-0001-5030-5919
Cahill, Daniel P.
Adalsteinsson, Viktor A. http://orcid.org/0000-0003-4555-2485
Miller, Jeffrey W.
Sullivan, Ryan J. http://orcid.org/0000-0001-5344-6645
Carter, Scott L. http://orcid.org/0000-0002-8480-1475
Brastianos, Priscilla K. http://orcid.org/0000-0003-4470-8425
Shalek, Alex K. http://orcid.org/0000-0001-5670-8778
Funding for this research was provided by:
Arnold and Mabel Beckman Foundation
Pew Charitable Trusts
Alfred P. Sloan Foundation
Bill and Melinda Gates Foundation
Susan G. Komen
Dana-Farber/Harvard Cancer Center
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
American Brain Tumor Association
American Association of Neurological Surgeons
Damon Runyon Cancer Research Foundation
Melanoma Research Alliance
Breast Cancer Research Foundation
Article History
Received: 14 November 2020
Accepted: 25 August 2021
First Online: 12 October 2021
Change Date: 25 November 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-021-27207-6
Competing interests
: A.K.S. has received compensation for consulting and SAB membership from Honeycomb Biotechnologies, Dot Bio, Cellarity, Cogen Therapeutics, Dahlia Biosciences, and Ochre Bio. P.K.B. has received compensation for consulting from Lilly, Angiochem, ElevateBio, Voyager Therapeutics, Tesaro and Genentech-Roche, SK Life Sciences, Pfizer and Dantari and Speaker’s Honoraria from Genentech-Roche and Merck Sharp & Co. PKB has received research funding (to MGH) from Merck & Co, BMS, Eli Lilly, Mirati and Pfizer. D.P.C. has received compensation for consulting from Eli Lilly & Co. and received honoraria from Merck & Co. DR has consulting and compensation interests in Celsius Therapeutics. S.M.P., C.A.A., S.C.M., S.L.C., P.K.B., and A.K.S. are co-inventors on a provisional patent application filed by the Broad Institute relating to the techniques and findings described in this manuscript. The other authors have no competing interests.